prostratin has been researched along with HIV in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, L; Li, M; Lin, J; Pan, X; Zeng, X; Zhang, M; Zhao, W | 1 |
DeChristopher, BA; Loy, BA; Marsden, MD; Schrier, AJ; Wender, PA; Zack, JA | 1 |
Guo, J; Li, Z; Wu, Y; Zhou, Q | 1 |
Brown, SJ; De Clercq, E; Fikkert, V; Hantson, A; Hezareh, M; Pannecouque, C; Van Remoortel, B; Witvrouw, M | 1 |
Bisgrove, D; Chen, LF; Fenard, D; Greene, WC; Kwon, H; Verdin, E; Williams, SA | 1 |
Alcamí, J; Beltán, M; Bermejo, M; Brown, SJ; García-Pérez, J; González, N; Hezareh, M; Rullas, J | 1 |
6 other study(ies) available for prostratin and HIV
Article | Year |
---|---|
[Euphorbia fischeriana extract reactivates latent HIV through nuclear factor-κB pathway].
Topics: Euphorbia; Flow Cytometry; HIV; HIV Infections; Humans; NF-kappa B; Nitriles; Phorbol Esters; Plant Extracts; Signal Transduction; Sulfones; Tumor Necrosis Factor-alpha; Virus Latency | 2015 |
Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro.
Topics: Animals; Anti-HIV Agents; Bryostatins; Cell Line; Chemical Engineering; Drug Design; HIV; Humans; Phorbol Esters; Protein Kinase C; Rats; Virus Activation | 2012 |
The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.
Topics: Anti-HIV Agents; Azepines; Cell Cycle Proteins; Cyclin-Dependent Kinase 9; HeLa Cells; HIV; Humans; Jurkat Cells; Nuclear Proteins; Phorbol Esters; Phosphorylation; Positive Transcriptional Elongation Factor B; Promoter Regions, Genetic; Ribonucleoproteins, Small Nuclear; RNA Polymerase II; tat Gene Products, Human Immunodeficiency Virus; Transcription Factors; Transcriptional Activation; Transcriptional Elongation Factors; Triazoles; Virus Latency | 2013 |
Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entry.
Topics: Cell Line; Genotype; HIV; HIV Envelope Protein gp160; Humans; Membrane Fusion; Phorbol Esters; Recombination, Genetic; Simian Immunodeficiency Virus | 2003 |
Prostratin antagonizes HIV latency by activating NF-kappaB.
Topics: Active Transport, Cell Nucleus; CD4-Positive T-Lymphocytes; Gene Expression Regulation, Viral; HIV; HIV Long Terminal Repeat; Humans; I-kappa B Kinase; Jurkat Cells; NF-kappa B; Phorbol Esters; Phosphorylation; Protein Kinase C; Protein Serine-Threonine Kinases; Virus Latency | 2004 |
Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes.
Topics: Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; HIV; HIV Long Terminal Repeat; Humans; Leukocytes, Mononuclear; NF-kappa B; Phorbol Esters; Receptors, CCR5; Receptors, CXCR4; Receptors, HIV; Time Factors; Transcriptional Activation; Transfection; Virus Activation | 2004 |